Cargando…

Clinical Evaluation of Tumour Marker Combinations in the Differential Diagnosis of Benign and Malignant Liver Disease

CEA, CA19-9 and CA50 are tumour associated antigens defined by monoclonal antibodies which have been raised against adenocarcinoma cell lines. The aim of this study was to determine whether their combined use could improve diagnostic accuracy in patients with primary and secondary liver tumours. An...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lucarotti, M. E., Rothnie, N. D., Kelly, S. B., Hershman, M. J., Johanssen, C., Nilsson, O., Lindholm, L., Wood, C. B., Williamson, R. C. N., Habib, N. A.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 1991
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442938/ https://www.ncbi.nlm.nih.gov/pubmed/1777407 http://dx.doi.org/10.1155/1991/23874

Ejemplares similares

The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease.
por: Habib, N. A., et al.
Publicado: (1986)

Distinguishing benign from malignant liver tumours
por: Heiken, Jay P.
Publicado: (2007)

Prostacyclin and thromboxane in benign and malignant breast tumours.
por: Laekeman, G. M., et al.
Publicado: (1986)

Prostaglandin F2 alpha in benign and malignant breast tumours.
por: Vergote, I. B., et al.
Publicado: (1985)

Ablative techniques for the treatment of benign and malignant breast tumours
por: Peek, Mirjam C. L., et al.
Publicado: (2017)

Expression of Potential Dermal Progenitor Cell Markers in the Tumour and Stroma of Skin Adnexal Malignant and Benign Tumours
por: Quist, Sven R., et al.
Publicado: (2019)

In vivo uptake of labelled oestradiol by benign and malignant tumours of the human breast.
por: O'Higgins, N. J., et al.
Publicado: (1973)

Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.
por: van der Zee, A. G., et al.
Publicado: (1992)

An immunohistochemical perspective of PPARβ and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours
por: Ahmed, N, et al.
Publicado: (2008)

Relationship between cathepsin D, urokinase, and plasminogen activator inhibitors in malignant vs benign breast tumours.
por: Foucré, D., et al.
Publicado: (1991)

Platelet sensitivity to prostacyclin in normal subjects, and in patients with benign and malignant tumours of the breast.
por: Benedetto, C., et al.
Publicado: (1985)

Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours
por: Wojtas, Bartosz, et al.
Publicado: (2017)

Indications for liver surgery in benign tumours
por: Fodor, Margot, et al.
Publicado: (2018)

Glutathione S-transferase expression in benign and malignant ovarian tumours.
por: Green, J. A., et al.
Publicado: (1993)

Malignant Arrhythmia with Benign Tumour: Fibrolipoma of the Left Ventricle
por: Sajeev, Chakanalil Govindan, et al.
Publicado: (2014)

Multiexponential T2 relaxometry of benign and malignant adipocytic tumours
por: Nikiforaki, Katerina, et al.
Publicado: (2020)

Stearic acid and carcinogenesis.
por: Habib, N. A., et al.
Publicado: (1987)

MAGE, BAGE and GAGE: tumour antigen expression in benign and malignant ovarian tissue.
por: Gillespie, A. M., et al.
Publicado: (1998)

Ficolin-2 and ficolin-3 in women with malignant and benign ovarian tumours
por: Szala, Agnieszka, et al.
Publicado: (2013)

Possible differences between the karyotypes of preinvasive lesions and malignant tumours.
por: Atkin, N. B., et al.
Publicado: (1969)

Bisphosphonate Treatment of Benign Multifocal and Unifocal Osteolytic Tumours of Bone
por: Gibbons, C. L. M. H., et al.
Publicado: (2003)

Novel Molecular Markers of Malignancy in Histologically Normal and Benign Breast
por: Nasir, Aejaz, et al.
Publicado: (2011)

The Metabolically Benign and Malignant Fatty Liver
por: Stefan, Norbert, et al.
Publicado: (2011)

Contrast-enhanced ultrasound of benign and malignant liver lesions in children
por: Fang, Cheng, et al.
Publicado: (2021)

Comparison of benign and malignant follicular thyroid tumours by comparative genomic hybridization.
por: Hemmer, S., et al.
Publicado: (1998)

Two-Stage Carcinogenesis: Effect of length of Promoting Treatment on the Yield of Benign and Malignant Tumours
por: Roe, F. J. C., et al.
Publicado: (1963)

Duplication of the long arm of chromosome 1 in a malignant vaginal tumour.
por: Atkin, N. B., et al.
Publicado: (1978)

Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours.
por: Wilson, K. E., et al.
Publicado: (1996)

Prevalence of Spontaneous Benign and Malignant Mammary Tumours in RIIIb Mice According to Age and Parity
por: Pullinger, B. D.
Publicado: (1955)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

Whole-genome methylation analysis of benign and malignant colorectal tumours
por: Beggs, Andrew D, et al.
Publicado: (2013)

Benign tumours of the bone: A review()
por: Hakim, David N., et al.
Publicado: (2015)

Benign and malignant thyroid nodules with autoimmune thyroiditis
por: Kassi, Georgia N., et al.
Publicado: (2022)

Differential expression of translation-associated genes in benign and malignant human breast tumours.
por: Adams, S. M., et al.
Publicado: (1992)

Scoping review of clinical practice guidelines on the management of benign liver tumours
por: Haring, Martijn P D, et al.
Publicado: (2021)

Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary.
por: Orre, M., et al.
Publicado: (1998)

Bile duct adenoma: rare benign liver tumour
por: Teng, Thomas Zheng Jie, et al.
Publicado: (2021)

A low pH enzyme linked immunoassay using two monoclonal antibodies for the serological detection and monitoring of breast cancer.
por: Dhokia, B., et al.
Publicado: (1986)

Focal eosinophilic infiltration of the liver, benign or malignant?
por: Claeys, Wouter, et al.
Publicado: (2021)

Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions
por: Miédougé, M, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_84qt04b24tkd973iobco7qrli7